Pharmacogenetic testing can inform medication choice and adverse effect risk, while questions remain about implementation, data storage, and access in routine care.

Chieti, Italy - A variant of the COX-2 gene has been found that is associated with a decreased risk of MI and stroke [1]. The authors of the study claim that a test for this polymorphism, which has ...

A LAMP-based, visually read assay enables rapid FSHR N680S genotyping from buccal swabs, potentially allowing pre-cycle selection of recombinant FSH versus hMG to optimize ovarian stimulation.

At-home DNA tests have revolutionized personal health insights, but understanding their accuracy requires examining the ...

Despite global vaccination efforts, COVID-19 continues to pose significant risks, leading to severe complications and fatalities. These risks are driven by disrupted coagulation, impaired fibrinolysis ...